Showing 1 - 20 results of 36 for search '"СУБКЛИНИЧЕСКИЙ АТЕРОСКЛЕРОЗ"', query time: 0.70s Refine Results
  1. 1
    Academic Journal

    Source: Gastroenterologìa, Vol 49, Iss 2.56, Pp 67-72 (2015)
    GASTROENTEROLOGY; № 2.56 (2015); 67-72
    Гастроэнтерология-Gastroenterologìa; № 2.56 (2015); 67-72
    Гастроентерологія-Gastroenterologìa; № 2.56 (2015); 67-72

    File Description: application/pdf

  2. 2
  3. 3
  4. 4
  5. 5
    Academic Journal

    Contributors: The study was performed with the support of the North-Western State Medical University named after I.I. Mechnikov., Исследование проведено при поддержке Северо-Западного государственного медицинского университета имени И.И. Мечникова.

    Source: Rational Pharmacotherapy in Cardiology; Vol 18, No 1 (2022); 67-72 ; Рациональная Фармакотерапия в Кардиологии; Vol 18, No 1 (2022); 67-72 ; 2225-3653 ; 1819-6446

    File Description: application/pdf

    Relation: https://www.rpcardio.com/jour/article/view/2672/2284; Бойцов С.А., Зайратьянц О.В., Андреев Е.М., Самородская И.В. Сравнение показателей смертности от ишемической болезни сердца среди мужчин и женщин старше 50 лет в России и США. Российский Кардиологический Журнал 2017;(6):100-7. DOI:10.15829/1560-4071-2017-6-100-107.; Недогода С.В., Чаляби Т.А. Сосудистая жесткость и скорость распространения пульсовой волны: новые факторы риска сердечно-сосудистых осложнений и мишени для фармакотерапии. Болезни Сердца и Сосудов. 2006;(4):21-32.; Кобалава Ж.Д., Котовская Ю.В., Виллевальде С.В., и др. Артериальная жесткость и хроническая болезнь почек: причины и последствия. Рациональная Фармакотерапия в Кардиологии. 2014;10(1):83-91. DOI:10.20996/1819-6446-2014-10-1-83-91.; Васюк Ю.А., Иванова С.В., Школьник Е.Л., и др. Согласованное мнение российских экспертов по оценке артериальной жесткости в клинической практике. Кардиоваскулярная Терапия и Профилактика. 2016;15(2):4-19. DOI:10.15829/1728-8800-2016-2-4-19.; Недогода С.В. Эластичность крупных сосудов — новая мишень фармакотерапии. М.: Медиа Медика; 2008.; Кобалава Ж.Д., Конради А.О., Недогода С.В., Шляхто Е.В., Арутюнов Г.П., Баранова Е.И., и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский Кардиологический Журнал. 2020;25(3):3786. DOI:10.15829/1560-4071-2020-3-3786.; Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290-6. DOI:10.1159/000343145.; Национальные рекомендации по ведению пациентов с заболеваниями брахиоцефальных артерий (Российский согласительный документ). М.: Издательство НЦССХ им. А. Н. Бакулева РАМН; 2013.; Lang RM, Biering M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79-108. DOI:10.1016/j.euje.2005.12.014.; The Reference Values for Arterial Stiffness Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J. 2010;31(19):2338-50. DOI:10.1093/eurheartj/ehq165.; Janić M, Lunder M, Sabovič M. Arterial stiffness and cardiovascular therapy. Biomed Res Int. 2014;2014:621437. DOI:10.1155/2014/621437.; Gosse P, Pichot V, Guilhot M, et al. Relationship of cardiac involvement with arterial stiffness in a general population of 65-year-olds in the PROOF study. J Hypertens. 2010;28(2):389-394. DOI:10.1097/HJH.0b013e328333d1a4.; Kohara K. Central blood pressure, arterial stiffness and the heart in hypertensive patients. Hypertens Res. 2009;12(32):1056-8. DOI:10.1038/hr.2009.171.; Raphael CE, Cooper R, Parker KH, et al. Mechanisms of myocardial ischemia in hypertrophic cardiomyopathy: insights from wave intensity analysis and magnetic resonance. J Am Coll Cardiol. 2016;68(15):1651-60. DOI:10.1016/j.jacc.2016.07.751.; O’Rourke MF, Safar ME, Dzau V. The Cardiovascular Continuum extended: Aging effects on the aorta and microvasculature. Vasc Med. 2010;15(6):461-8. DOI:10.1177/1358863X10382946.; Tsiachris D, Tsioufis C, Syrseloudis D, et al. Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses. J Hum Hypertens. 2012;26(1):64-70. DOI:10.1038/jhh.2010.127.; George KP, Naylor LH, Whyte GP, et al. Diastolic function in healthy humans: non-invasive assessment and the impact of acute and chronic exercise. Eur J Appl Physiol. 2010;108(1):1-14. DOI:10.1007/s00421-009-1233-0.; Salvi P, Scalise F, Rovina M, et al. Noninvasive Estimation of Aortic Stiffness Through Different Approaches. Hypertension. 2019;74(1):117-29. DOI:10.1161/HYPERTENSIONAHA.119.12853.; Chirinos JA, Segers P, Hughes T, Townsend R. Large-Artery Stiffness in Health and Disease. J Am Coll Cardiol. 2019;74(9):1237-63. DOI:10.1016/j.jacc.2019.07.012.; https://www.rpcardio.com/jour/article/view/2672

  6. 6
    Academic Journal

    Contributors: The study was performed with the support of the National Medical Research Center for Therapy and Preventive Medicine., Исследование проведено при поддержке Национального медицинского исследовательского центра терапии и профилактической медицины.

    Source: Rational Pharmacotherapy in Cardiology; Vol 18, No 2 (2022); 165-169 ; Рациональная Фармакотерапия в Кардиологии; Vol 18, No 2 (2022); 165-169 ; 2225-3653 ; 1819-6446

    File Description: application/pdf

    Relation: https://www.rpcardio.com/jour/article/view/2711/2298; Polonsky TS, Greenland P. CVD screening in low-risk, asymptomatic adults: clinical trials needed. Nat Rev Cardiol. 2012;9(10):599-604. DOI:10.1038/nrcardio.2012.114.; Spence JD. Technology Insight: ultrasound measurement of carotid plaque-patient management, genetic research, and therapy evaluation. Nat Clin Pract Neurol. 2006;2(11):611-9. DOI:10.1038/ncpneuro0324.; Spence JD, Barnett PA, Bulman DE, et al. An approach to ascertain probands with a nontraditional risk factor for carotid atherosclerosis. Atherosclerosis. 1999;144(2):429-34. DOI:10.1016/s0021-9150(99)00003-9.; Strong JP, Malcom GT, McMahan CA, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA.1999;281(8):727-35. DOI:10.1001/jama.281.8.727.; Ершова А.И., Бойцов С.А., Драпкина О.М., Балахонова Т.В. Ультразвуковые маркеры доклинического атеросклероза сонных и бедренных артерий в оценке сердечно-сосудистого риска. Российский Кардиологический Журнал. 2018;23(8):92-8. DOI:10.15829/15-60-4071-2018-8-92-98.; Spence JD, Eliasziw M, DiCicco M, et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33(12):2916-22. DOI:10.1161/01.str.0000042207.16156.b9.; Held C, Hjemdahl P, Eriksson SV, et al. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J. 2001;22(1):62-72. DOI:10.1053/euhj.1999.2006.; 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281-357. DOI:10.1097/01.hjh.0000431740.32696.cc.; Тимофеева Т.Н., Шальнова С.А., Константинов В.В., и др. Распространенность факторов, влияющих на прогноз больных артериальной гипертонией и оценка общего сердечно-сосудистого риска. Кардиоваскулярная Терапия и Профилактика. 2005;4(6) часть 1:15-24; Шальнова С.А., Деев А.Д., Карпов Ю.А. Артериальная гипертония и ишемическая болезнь сердца в реальной практике врача-кардиолога. Кардиоваскулярная Терапия и Профилактика. 2006;5(2):73-80.; Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. Arterioscler Thromb. 1993;13(5):661-8. DOI:10.1161/01.atv.13.5.661.; Mannami T, Konishi M, Baba S, et al. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke. 1997;28(3):518-25. DOI:10.1161/01.str.28.3.518.; Жернакова Ю. В., Кавешников В. С., Серебрякова В. Н., и др. Распространенность каротидного атеросклероза в неорганизованной популяции Томска. Системные Гипертензии. 2014;4:37-42.; Fernandez-Friera L, Penalvo JL, Fernandez-Ortiz A, et al. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation. 2015;131(24):2104-13]. DOI:10.1161/CIRCULATIONAHA.114.014310.; Protogerou AD, Fransen J, Zampeli E, et al. The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus. PLoS One. 2015;10(7):e0132307. DOI:10.1371/journal.pone.0132307.; Laclaustra M, Casasnovas JA, Fernandez-Ortiz A, et al. Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study. J Am Coll Cardiol. 2016;67(11):1263-74. DOI:10.1016/j.jacc.2015.12.056.; Dalager S, Falk E, Kristensen IB, et al. Plaque in superficial femoral arteries indicates generalized atherosclerosis and vulnerability to coronary death: an autopsy study. J Vasc Surg. 2008;47(2):296- 302. DOI:10.1016/j.jvs.2007.10.037.; Бовтюшко П.В., Гришаев С.Л., Филиппов А.Е. Атеросклеротическая бляшка в региональных сосудистых бассейнах общей сонной и бедренной артерий как маркер субклинического атеросклероза. Фундаментальные Исследования. 2012;8(2): 285-8.; Бойцов С.А., Кухарчук В.В., Карпов Ю.А., и др. Субклинический атеросклероз как фактор риска сердечно-сосудистых осложнений. Кардиоваскулярная Терапия и Профилактика. 2012;11(3):82-6 DOI:10.15829/1728-8800-2012-3-82-86.; https://www.rpcardio.com/jour/article/view/2711

  7. 7
  8. 8
    Academic Journal
  9. 9
    Academic Journal

    Source: Modern Rheumatology Journal; Том 15, № 5 (2021); 33-38 ; Современная ревматология; Том 15, № 5 (2021); 33-38 ; 2310-158X ; 1996-7012

    File Description: application/pdf

    Relation: https://mrj.ima-press.net/mrj/article/view/1194/1148; Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37(29):2315-81. doi:10.1093/eurheartj/ehw106.; Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233-41. doi:10.1038/35025203.; Hall FC, Dalbeth N. Disease modification and cardiovascular risk reduction: two sides of the same coin?. Rheumatology (Oxford). 2005;44(12):1473-82. doi:10.1093/rheumatology/kei012.; Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther.2008;10(2):R30. doi:10.1186/ar2383.; Agca R, Heslinga SC, Rollefstad S, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17-28. doi:10.1136/annrheumdis-2016-209775.; Bierma-Zeinstra SMA, Waarsing JH. The role of atherosclerosis in osteoarthritis. Best Pract Res Clin Rheumatol. 2017;31(5):613-33. doi:10.1016/j.berh.2018.08.006.; Елисеев МС, Желябина ОВ, Чикина МН, Новикова АМ. Факторы риска сердечно-сосудистых заболеваний у пациентов с болезнью депонирования кристаллов пирофосфата кальция. Научно-практическая ревматология. 2019;57(5):545-52.; Елисеев МС, Новикова АМ, Желябина ОВ и др. Оценка сердечно-сосудистого риска у пациентов с микрокристаллическими артритами и ревматоидным артритом с помощью шкал ATP III и Reynolds Risk Score. Научно-практическая ревматология. 2020;58(5):512-9.; Beck C, Morbach H, Richl P, et al. How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases? Rheumatol Int. 2009;29(3):229-38. doi:10.1007/s00296-008-0710-9.; Hall AJ, Stubbs B, Mamas MA, et al. Association between osteoarthritis and cardiovascular disease: Systematic review and meta-analysis. Eur J Prev Cardiol. 2016; 23(9):938-46. doi:10.1177/2047487315610663.; Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013;21(1): 16-21. doi:10.1016/j.joca.2012.11.012.; Hoeven TA, Leening MJ, Bindels PJ, et al. Disability and not osteoarthritis predicts cardiovascular disease: a prospective population- based cohort study. Ann Rheum Dis. 2015;74(4):752-6. doi:10.1136/annrheumdis-2013-204388.; Loef M, van der Geest RJ, Lamb HJ, et al. Mediation of the association between obesity and osteoarthritis by blood pressure, vessel wall stiffness and subclinical atherosclerosis. Rheumatology (Oxford). 2021 Jul 1;60(7): 3268-77. doi:10.1093/rheumatology/keaa778.; Abhishek A, Doherty S, Maciewicz R, et al. Association between low cortical bone mineral density, soft-tissue calcification, vascular calcification and chondrocalcinosis: a case-control study. Ann Rheum Dis. 2014; 73(11):1997-2002. doi:10.1136/annrheumdis-2013-203400.; Hollander JL, Jessar RA, McCarty DJ. Synovianalysis: an aid in arthritis diagnosis. Bull Rheum Dis. 1961 Dec;12:263-4.; Насонов ЕЛ, редактор. Российские клинические рекомендации. Ревматология. Москва: ГЭОТАР-Медиа; 2020. 340 с.; Zhang W, Doherty M, Peat G, et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis. 2010 Mar;69(3):483-9. doi:10.1136/ard.2009.113100. Epub 2009 Sep 17.; World Health Organization (WHO). Obesity: prevention and management of the global epidemic. Report of the WHO Consultation. World Health Organ Tech Rep Ser. 2000;894(i-xii):1-253.; Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013; 34(38):2949-3003. doi:10.1093/eurheartj/eht296.; Комитет экспертов РКО. Национальные рекомендации по кардиоваскулярной профилактике. Кардиоваскулярная терапия и профилактика. 2011;10 (6 Прил. 2):1-64.; Fernandez-Friera L, Fuster V, Lopez-Melgar B, et al. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors. J Am Coll Cardiol. 2017;70(24): 2979-91. doi:10.1016/j.jacc.2017.10.024.; Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol. 2010;30(2):182-5. doi:10.1161/ATVBAHA.109.196980; Qu B, Qu T. Causes of changes in carotid intima-media thickness: a literature review. Cardiovasc Ultrasound. 2015 Dec 15;13:46. doi:10.1186/s12947-015-0041-4.; Кавешников ВС, Серебрякова ВН, Трубачева ИА. Процентильное распределение толщины комплекса «интима-медиа» в общей популяции трудоспособного возраста. Сибирский медицинский журнал. 2019;34(1):145-51.; Baldassarre D, Hamsten A, Veglia F, et al. Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (Carotid Intima Media Thickness [IMT] and IMTProgression as Predictors of Vascular Events in a High Risk European Population) study. J Am Coll Cardiol. 2012;60(16):1489-99. doi:10.1016/j.jacc.2012.06.034.; Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290(7):898-904. doi:10.1001/jama.290.7.898.; Kwon GP, Schroeder JL, Amar MJ, et al. Contribution of macromolecular structure to the retention of low-density lipoprotein at arterial branch points. Circulation. 2008; 117(22):2919-27. doi:10.1161/CIRCULATIONAHA.107.754614.; Perez-Ruiz F, Martinez-Indart L, Carmona L, et al. Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis. 2014;73(1):177-82. doi:10.1136/annrheumdis-2012-202421.; Mathieu S, Couderc M, Tournadre A, Soubrier M. Cardiovascular profile in osteoarthritis: a meta-analysis of cardiovascular events and risk factors. Joint Bone Spine. 2019;86(6):679-84. doi:10.1016/j.jbspin.2019.06.013.; Perk J, De Backer G, Gohlke H, et al. European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J. 2012;33(13):1635-701.doi:10.1093/eurheartj/ehs092.

  10. 10
  11. 11
  12. 12
    Academic Journal

    Source: Bulletin of Siberian Medicine; Том 19, № 2 (2020); 182-188 ; Бюллетень сибирской медицины; Том 19, № 2 (2020); 182-188 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2020-19-2

    File Description: application/pdf

    Relation: https://bulletin.tomsk.ru/jour/article/view/2875/1755; https://bulletin.tomsk.ru/jour/article/view/2875/1780; Li B., Li W., Li X., Zhou H. Inflammation: a novel therapeutic target/direction in atherosclerosis. Curr. Pharm. Des. 2017; 23 (8): 1216–1227. DOI:10.2174/1381612822666161230142931.; Barquera S., Pedroza-Tobias A., Medina C., Hernandez-Barrera L., Bibbins-Domingo K., Lozano R., Moran A.E. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch. Med. Res. 2015; 46 (5): 328–338. DOI:10.1016/j.arcmed.2015.06.006.; Kalra D.K., Heo R., Valenti V., Nakazato R., Min J.K. Role of computed tomography for diagnosis and risk stratification of patients with suspected or known coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2014; 34 (6): 1144–1154. DOI:10.1161/ATVBAHA.113.302074.; GBD 2013 mortality and causes of death collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385 (9963): 117–171. DOI:10.1016/S0140-6736(14)61682-2.; Здравоохранение в России. 2017: статистический сборник. М., 2017: 170.; Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Российский кардиологический журнал. 2018; 6: 7–122. DOI:10.15829/1560-4071-2018-6-7-122.; Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L., Cooney M.T., Corrà U., Cosyns B., Deaton C., Graham I., Hall M.S., Hobbs F.D.R,. Løchen M.L., Löllgen H, Marques-Vidal P., Perk J., Prescott E., Redon J., Richter D.J., Sattar N., Smulders Y., Tiberi M., van der Worp H.B., van Dis I., Verschuren W.M.M., Binno S. ESC scientific document group. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European association for cardiovascular prevention & rehabilitation (EACPR). Eur. Heart J. 2016; 37 (29): 2315–2381. DOI:10.1093/eurheartj/ehw106.; Rose G. Sick individuals and sick populations. 1985. Bull. World Health Organ. 2001; 79 (10): 990–996.; Кобалава Ж.Д., Конради А.О., Недогода С.В., Арутюнов Г.П., Баранова Е.И., Барбараш О.Л., Виллевальде С.В., Галявич А.С., Глезер М.Г., Драпкина О.М., Котовская Ю.В., Либис Р.А., Лопатин Ю.М., Недошивин А.О., Остроумова О.Д., Ратова Л.Г., Ткачева О.Н., Чазова И.Е., Чесникова А.И., Чумакова Г.А. Меморандум экспертов Российского кардиологического общества по рекомендациям Европейского общества кардиологов/Европейского общества по артериальной гипертензии по лечению артериальной гипертензии 2018 г. Российский кардиологический журнал. 2018; 23 (12): 131–142. DOI:10.15829/1560-4071-2018-12-131-142.; Dragano N., Siegrist J., Nyberg S.T., Lunau T., Fransson E.I., Alfredsson L., Bjorner J.B., Borritz M., Burr H., Erbel R., Fahlén G., Goldberg M., Hamer M., Heikkilä K., Jöckel K.H., Knutsson A., Madsen I., Nielsen M.L., Nordin M., Oksanen T., Pejtersen J.H., Pentti J., Rugulies R., Salo P., Schupp J., Singh-Manoux A., Steptoe A., Theorell T., Vahtera J., Westerholm P., Westerlund H., Virtanen M., Zins M., Batty G.D., Kivimäki M. IPD-work consortium (2017). Effort-reward imbalance at work and incident coronary heart disease: a Multicohort Study of 90,164 individuals. Epidemiology (Cambridge, Mass.). 2017; 28 (4): 619–626. DOI:10.1097/EDE.0000000000000666.; Polak J.F., Szklo M., Kronmal R.A., Burke G.L., Shea S, Zavodni A.E., O’Leary D.H. The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. J. Am. Heart Assoc. 2013 April; 2 (2): e000087. DOI:10.1161/JAHA.113.000087.; Blaha M.J., Yeboah J., Al Rifai M., Liu K., Kronmal R., Greenland P. Providing evidence for subclinical CVD in risk assessment. Glob. Heart. 2016 Sept.; 11 (3): 275–285. DOI:10.1016/j.gheart.2016.08.003.; Delaney J.A., Jensky N.E., Criqui M., Whitt-Glover M.C., Lima J.A., Allison M.A. The association between physical activity and both incident coronary artery calcification and ankle brachial index progression: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2013; 230 (2): 278–232. DOI:10.1016/j.jcmg.2015.06.030.; Cohen R., Budoff M., McClelland R.L., Sillau S., Burke G., Blaha M., Szklo M., Uretsky S., Rozanski A., Shea S. Significance of a positive family history for coronary heart disease in patients with a zero coronary artery calcium score (from the Multi-Ethnic Study of Atherosclerosis). Am. J. Cardiol. 2014; 114 (8): 1210–1214. DOI:10.1016/j.amjcard.2014.07.043.; Pandey A.K., Blaha M.J., Sharma K., Rivera J., Budoff M.J., Blankstein R., Al-Mallah M., Wong N.D., Shaw L., Carr J., O’Leary D., Lima J.A., Szklo M., Blumenthal R.S., Nasir K. Family history of coronary heart disease and the incidence and progression of coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2014; 232 (2): 369–376. DOI:10.1016/j.atherosclerosis.2013.11.042.; Yeboah J., Young R., McClelland R.L., Delaney J.C., Polonsky T.S., Dawood F.Z., Blaha M.J., Miedema M.D., Sibley C.T., Carr J.J., Burke G.L., Goff D.C. Jr, Psaty B.M., Greenland P., Herrington D.M. Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J. Am. Coll. Cardiol. 2016; 67 (2): 139–147. DOI:10.1016/j.jacc.2015.10.058.; https://bulletin.tomsk.ru/jour/article/view/2875

  13. 13
    Academic Journal

    Source: Complex Issues of Cardiovascular Diseases; Том 7, № 1 (2018); 21-28 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 7, № 1 (2018); 21-28 ; 2587-9537 ; 2306-1278 ; 10.17802/2306-1278-2018-7-1

    File Description: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/389/308; Martinez-Larrad M. T., Anchuelo A. C., Del Prado N., Ibarra Rueda J-M., Gabriel R., Serrano-Ríos M. Profile of individuals who are metabolically healthy obese using different definition criteria : a population-based analysis in the Spanish population. PLoS One. 2014; 9( 9): e106641. doi:10.1371/ journal.pone.0106641; Talman A. H., Psaltis P.J., Cameron J.D., Meredith I.T., Seneviratne S.K., Wong D.T. Epicardial adipose tissue: far more than a fat depot. Cardiovascular Diagnosis and Therapy. 2014; 4 (6): 416-429.; Iacobellis G., Willens H. J. Echocardiographic epicardial fat: a review of research and clinical applicationsThe Journal of the American Society of Echocardiography. 2009. 22(12):1311-1319; quiz 1417-8. doi:10.1016/j. echo.2009.10.013.; Iacobellis G., Assael F., Ribaudo M.C., Zappaterreno A., Alessi G., Di Mario U., Leonetti F. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obesity Research. 2003; 11: 304-310.; Чумакова Г. А., Веселовская Н. Г., Гриценко О.В., Вахромеева Е.В., Субботин Е.А. Эпикардиальное ожирение как возможный маркер метаболическогосиндрома. Кардиосоматика. 2012; 4: 38-43.; Bluher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Practice & Research Clinical Endocrinology & Metabolism. 2013; 27: 163-177.; Romacho T., Elsen M., Rohrborn, D., Eckel J. Adipose tissue and its role in organ crosstalk. // Acta Physiologica (Oxf.). 2014; 210: 733-753.; Rabkin S. W. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. 2014; 12 (1): 31-42.; Eroğlu S. How do we measure epicardial adipose tissue thickness by transthoracic echocardiography? The Anatolian Journal of Cardiology. 2015;15 (5):P. 416-419.; Meenakshi K., Rajendran M., Srikumar S. Epicardial fat thickness: A surrogatemarkerofcoronaryarterydisease:Assessmentbyechocardiography. Indian Heart Journal. 2016; 68 (3): 336-341.; Baragetti A., Pisano G., Bertelli C., Garlaschelli K., Grigore L., Fracanzani A.L. et al. Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population. Nutrition, Metabolism & Cardiovascular Diseases. 2016; 26 (2):141-153. doi:10.1016/j.numecd.2015.10.013.; Kocaman S. A., Baysan O., Cetin M., Kayhan A.T., Polat Ocaklı E., Durakoğlugil M.E. et al. An increase in epicardial adipose tissue is strongly associated with carotid-intima media thickness and atherosclerotic plaque, but LDL only with the plaque. The Anatolian Journal of Cardiology [Anadulu Kardiyoloji Dergisi: AKD]. 2017; 17 (1): 56. doi:10.14744/AnatolJCardiol.2016.6885; 13.BoyrazM.,PirgonO.,AkyolB.,DundarB.,CekmezF.,ErenN.Importance of epicardial adipose tissue thickness measurement in obese adolescents, its relationship with carotid intima-media thickness, and echocardiographic findings. European Review for Medical and Pharmacological Sciences. 2013; 17: 33093317.; Nelson M. R., Mookadam F.,ThotaV., Emani U., Al Harthi M., Lester .SJ. et al. Epicardial fat: An additional measurement for subclinical atherosclerosis and cardiovascular risk stratification? The Journal of the American Society of Echocardiography. 2011; 24: 339-345. doi:10.1016/j.echo.2010.11.008.; Salari A., Shakiba M., Mahdavi-Roshan M., Gholipour M., Naghshbandi M., Rajab R. The association between various indices of obesity and severity of atherosclerosis in adults in the north of Iran. Medicine. 2016; 95 (50): E5670. doi:10.1097/MD.0000000000005670; Cheng F.W., Gao X., Mitchell D.C., Wood C., Rolston D.D., Still C.D., Jensen G.L. Metabolic Health Status and the Obesity Paradox in Older Adults. Journal of Nutrition in Gerontology and Geriatrics. 2016; 35 (3): 161-176. – doi:10.1080/21551197.2016.1199004.; Liu J., Fox C.S., Hickson D., Bidulescu A., Carr J.J., Taylor H.A. Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2011; 31 (11): 2715-2722. doi:10.1161/ATVBAHA.111.234062; Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Letters. 2006; 580 (12): 2917-2921 DOI:10.1016/j.febslet.2006.04.028; Lindberg S., Mogelvang R., Pedersen S.H., Bjerre M., Frystyk J., Flyvbjerg A. Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study). The American Journal of Cardiology. 2013; 111 (8): P. 1139-1145. doi:10.1016/j.amjcard.2012.12.043.; Li Z., Guo X., Liu Y., Zhang N., Chang Ye, Chen Y. et al. Metabolism rather than obesity is associated with ischemic stroke: a cross sectional study in rural Northeastern China. SpringerPlus. 2016; 5 (1): 1419. doi 10.1186/s40064-016-30882; Lackey D. E., Burk D.H., Ali M.R., Mostaedi R., Smith W.H., Park J. et al. Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity. The American Journal of Physiology: Endocrinology and Metabolism. 2014; 306: E233-E246. doi:10.1152/ajpendo.00476.2013.; Kwon B. J., Kim D.W., Her S.H., Kim D.B., Jang S.W., Cho E.J. et al. Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease. Metabolism. 2013; 62 (7): 952-960. doi:10.1016/j.metabol.2013.01.006.

  14. 14
    Academic Journal

    Source: Scientific community of students; 25-26 ; Научное сообщество студентов; 25-26

    File Description: text/html

    Relation: info:eu-repo/semantics/altIdentifier/isbn/978-5-9908358-4-9; https://interactive-plus.ru/e-articles/315/Action315-112712.pdf; 1. Anitchkow N.N. Zbl. allg. Path. u. path. Anat / N.N. Anitchkow, S.S. Chalatow. – 1913.; 2. Аничков Н.Н. Современное состояние проблемы атеросклероза / Н.Н. Аничков, В.Д. Цинзерлинг. – 1953.; 3. Вальдман А.А. Н.Н. Аничков // А.А. Вальдман, В.А. Базанов // Выдающиеся деятели отечественной медицины и здравоохранения. – 1974.; 4. Crouse III J.R. Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals With Subclinical Atherosclerosis / III J.R. Crouse, J.S. Raichlen, W.A. Riley [et al.] // The METEOR Trial. JAMA. March 28. – 2007. – №297. – P. 1344–1353 (международное рандомизированное двойное слепое плацебо-контролируемое испытание Measuring Effects on Intima-Media Thickness: an Evaluation of Rosuvastatin).; 5. JUPITER Study group – Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of lowdensity lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation. – 2003. – №108. – P. 2292–2297.

  15. 15
  16. 16
    Academic Journal

    Source: Bukovinian Medical Herald; Vol. 18 No. 3 (71) (2014) ; Буковинский медицинский вестник; Том 18 № 3 (71) (2014) ; Буковинський медичний вісник; Том 18 № 3 (71) (2014) ; 2413-0737 ; 1684-7903

    File Description: application/pdf

  17. 17
  18. 18
  19. 19
  20. 20